Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections
The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Small colony variants constitute a slow-growing subpopulation of bacteria with distinctive phenotypic and pathogenic traits. Phenotypically, small colony variants have a slow growth rate, atypical colony morphology and unusual biochemical characteristics, making them a challenge for clinical microbiologists to identify. Clinically, small colony variants are better able to persist in mammalian cells and are less susceptible to antibiotics than their wild-type counterparts, and can cause latent or recurrent infections on emergence from the protective environment of the host cell. This Review covers the phenotypic, genetic and clinical picture associated with small colony variants, with an emphasis on staphylococci, for which the greatest amount of information is available.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Staphylococcus aureus is a frequent cause of chronic and recurrent infections, which often involve the emergence of slow-growing mutants known as small-colony variants (SCVs) (1–14).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [9]
In the citing paper
“SCVs with mutations in heme or menaquinone biosynthetic pathways have defective electron-transport chains, which confers resistance to aminoglycoside antibiotics such as gentamicin (1, 6, 8, 9).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [9]
In the citing paper
“In addition to aminoglycoside resistance, SCVs that arise via the loss of the electron transport chain are more tolerant than wild-type bacteria of other classes of bactericidal antibiotics (8, 9, 25–29).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [9]
In the citing paper
“Despite the importance of these defenses for wild-type S. aureus survival in the host, SCVs have been reported to produce significantly reduced levels of staphyloxanthin and heme auxotrophs are deficient in catalase, which would be expected to make them more susceptible to ROS generated by neutrophils and thus clearance from host tissues (9, 19, 28, 36, 45).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [9]
In the citing paper
“Despite the importance of these defenses for wild-type S. aureus survival in the host, SCVs have been reported to produce significantly reduced levels of staphyloxanthin and heme auxotrophs are deficient in catalase, which would be expected to make them more susceptible to ROS generated by neutrophils and thus clearance from host tissues (9, 19, 28, 36, 45).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [9]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(2019) · ASM Press eBooks · doi:10.1128/9781683670131 · Cited by 1,009
Sinha, B., Francois, P. P., Nusse, O., Foti, M., Hartford, O. M., Vaudaux, P., Foster, T. J., Lew, D. P., Herrmann, M., & Krause, K.-H. (1999) · Cellular Microbiology · doi:10.1046/j.1462-5822.1999.00011.x · Cited by 563
Self-citationInfections Associated with Indwelling Medical Devices
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-391_2 · Cited by 537
Persistent and Relapsing Infections Associated with Small-Colony Variants of Staphylococcus aureus
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N., & Arbeit, R. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.95 · Cited by 437
Self-citationKahl, B., Herrmann, M., Everding, A. S., Koch, H. G., Becker, K., Harms, E., Proctor, R. A., & Peters, G. (1998) · Journal of Infectious Diseases · doi:10.1086/515238 · Cited by 357
Self-citationIntracellular Staphylococcus aureus Escapes the Endosome and Induces Apoptosis in Epithelial Cells
Bayles, K. W., Wesson, C. A., Liou, L. E., Fox, L. K., Bohach, G. A., & Trumble, W. R. (1998) · Infection and Immunity · doi:10.1128/iai.66.1.336-342.1998 · Cited by 349 · cited 1×
“aureus is not only an extracellular pathogen but also an intracellular pathogen, owing to effective uptake of these bacteria by non-professional phagocytes, such as endothelial and epithelial cells, fibroblasts, osteoblasts and keratinocyte”
Backgroundvon Eiff, C., Heilmann, C., Proctor, R. A., Woltz, C., Peters, G., & Götz, F. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4706-4712.1997 · Cited by 310
Self-citationDziewanowska, K., Patti, J. M., Deobald, C. F., Bayles, K. W., Trumble, W. R., & Bohach, G. A. (1999) · Infection and Immunity · doi:10.1128/iai.67.9.4673-4678.1999 · Cited by 297 · cited 1×
“SCV internalization is mediated by fibronectin bridging between the bacterial fibronectin-binding proteins (FnBPs) and the receptor α 5 β 1 -integrin, which is present at the surface of eukaryotic cell”
Backgroundvon Eiff, C., Bettin, D., Proctor, R. A., Rolauffs, B., Lindner, N., Winkelmann, W., & Peters, G. (1997) · Clinical Infectious Diseases · doi:10.1086/516962 · Cited by 247
Self-citationSmall-Colony Variants of Pseudomonas aeruginosa in Cystic Fibrosis
Rohde, M. (1999) · Clinical Infectious Diseases · doi:10.1086/598644 · Cited by 238
Research works printed but not linked: 8
- Jacobsen, K. A. Mitteilungen über einen variablen Typhusstamm (Bacterium typhi mutabile), sowie über eine eigentümliche hemmende Wirkung des gewöhnlichen agar, verursacht durch autoklavierung. Zentralbl. Bakteriol. [Orig. A] 56, 208–216 (1910) (in German).
- Borderon, E. & Horodniceanu, T. Mutants déficients a colonies naines de Staphylococcus: ètude de trois souches isolées chez des malades porteurs d'osteosyntheses. Ann. Microbiol. (Paris) 127, 503–514 (1976) (in French).
- Thomas, M. E. M. & Cowlard, J. H. Studies on a CO2-dependent Staphylococcus. J. Clin. Pathol. 8, 288–291 (1955). · DOI · Paper page
- Slifkin, M., Merkow, L. P., Kreuzberger, S. A., Engwall, C. & Pardo, M. Characterization of CO2 dependent microcolony variants of Staphylococcus aureus. Am. J. Clin. Pathol. 56, 584–592 (1971). · DOI · Paper page
- Stryer, L. in Biochemistry 739–762 (Freeman and Company, New York, 1995).
- Salgado, D. R., Boza, F. A., Pinto, M. & Sampaio, J. Outbreak with small colony variants of methicillin-resistant Staphylococcus aureus in an ICU. Abstract K-1226. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago, Illinois, USA, 16–19 Dec 2001).
- Häussler, S., Tummler, B., Weissbrodt, H., Rohde, M. & Steinmetz, I. Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin. Infect. Dis. 29, 621–625 (1999). · DOI · Paper page
- Borderon, E., Horodniceanu, T., Buissiere, J. & Barthez, J. P. Mutants déficients à colonies naines de Escherichia coli: ètude d'une souche thiamine-déficiente isolée d'une uroculture. Ann. Microbiol. (Paris) 128A, 413–417 (1977) (in French).
Cited by
Items 201–300 of 1,000
Cameron, D. R., Howden, B. P., & Peleg, A. Y. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir473 · Cited by 81
Respiration and Small Colony Variants of Staphylococcus aureus
Proctor, R. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0069-2019 · Cited by 78
Self-citationLatimer, J., Forbes, S., & McBain, A. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05904-11 · Cited by 92
Tomatidine Is a Lead Antibiotic Molecule That Targets Staphylococcus aureus ATP Synthase Subunit C
Boulet, M. L., Isabelle, C., Guay, I., Brouillette, É., Langlois, J.-P., Jacques, P., Rodrigue, S., Brzeziński, R., Beauregard, P. B., Bouarab, K., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02197-17 · Cited by 85
“Respiratory deficiency is often caused by mutation in genes involved in hemin or menadione biosynthesis, which are important components of the respiratory chain (28).”
BackgroundInfluentialEvans, T. J. (2015) · Future Microbiology · doi:10.2217/fmb.14.107 · Cited by 77
Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular Bacterial Infections
Buccini, D. F., Cardoso, M. H. E. S., & Franco, O. L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.612931 · Cited by 80
Lerche, C. J., Schwartz, F. A., Theut, A. M., Fosbøl, E. L., Iversen, K. K., Bundgaard, H., Høiby, N., & Moser, C. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.643335 · Cited by 88
“For streptococci, SCVs have only been sparsely investigated and almost exclusively for S. pneumoniae.”
BackgroundInfluentialEffect of Low Temperature on Growth and Ultra-Structure of Staphylococcus spp
Onyango, L. A., Dunstan, R. H., Gottfries, J., von Eiff, C., & Roberts, T. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029031 · Cited by 72
The Impact of Capsid Proteins on Virus Removal and Inactivation during Water Treatment Processes
Mayer, B. K., Yang, Y., Gerrity, D. W., & Abbaszadegan, M. A. (2015) · Microbiology Insights · doi:10.4137/mbi.s31441 · Cited by 90
Kriegeskorte, A., Grubmüller, S., Huber, C., Kahl, B. C., von Eiff, C., Proctor, R. A., Peters, G., Eisenreich, W., & Becker, K. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00141 · Cited by 71
Self-citationWhat Distinguishes Highly Pathogenic Staphylococci from Medium- and Non-pathogenic?
Rosenstein, R., & Götz, F. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_286 · Cited by 98
Kussmann, M., Karer, M., Obermüller, M., Schmidt, K., Barousch, W., Moser, D., Nehr, M., Ramharter, M., Poeppl, W., Makristathis, A., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0205-z · Cited by 81
The social life of microbes in chronic infection
Ibberson, C. B., & Whiteley, M. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.02.003 · Cited by 87
“aureus, leading to the adoption of a fermentative metabolism [63], and often the formation of small colony variants (SCVs) [54, 64].”
BackgroundIntracellular Staphylococcus aureus and host cell death pathways
Soe, Y. M., Bedoui, S., Stinear, T. P., & Hachani, A. (2021) · Cellular Microbiology · doi:10.1111/cmi.13317 · Cited by 88
Review on skeletal disorders caused by Staphylococcus spp. in poultry
Szafraniec, G. M., Szeleszczuk, P., & Dolka, B. (2022) · Veterinary Quarterly · doi:10.1080/01652176.2022.2033880 · Cited by 91
“Additionally, SCVs show increased resistance to antimicrobial treatment (Proctor et al. 2006).”
BackgroundInfluentialOnyango, L. A., Dunstan, R. H., Roberts, T. K., Macdonald, M. M., & Gottfries, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077614 · Cited by 77
Nina, H., Block, D., Bianconi, I., Bragonzi, A., Birtel, J., Lee, J. C., Dübbers, A., Küster, P., Janina, K., Peters, G., et al. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.09.012 · Cited by 84
Self-citationBacterial involvement in otitis media with effusion
Daniel, M., Imtiaz-Umer, S., Fergie, N., Birchall, J. P., & Bayston, R. (2012) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2012.06.013 · Cited by 77
Control of the Physical and Antimicrobial Skin Barrier by an IL-31–IL-1 Signaling Network
Hänel, K. H., Pfaff, C. M., Cornelissen, C., Amann, P. M., Marquardt, Y., Czaja, K., Kim, A., Lüscher, B., & Baron, J. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1402943 · Cited by 77
Staphylococcus aureus strategies to evade the host acquired immune response
Goldmann, O., & Medina, E. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.09.013 · Cited by 76
Mitchell, G., Brouillette, É., Séguin, D. L., Asselin, A.-E., Jacob, C. L., & Malouin, F. (2009) · Microbial Pathogenesis · doi:10.1016/j.micpath.2009.10.003 · Cited by 89
Valour, F., Rasigade, J., Trouillet‐Assant, S., Gagnaire, J., Bouaziz, A., Karsenty, J., Lacour, C., Bes, M., Lustıg, S., Bénet, T., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.01.026 · Cited by 81
The Genetic Basis of Escherichia coli Pathoadaptation to Macrophages
Miskinyte, M., Sousa, A., Ramiro, R. S., de Sousa, J. A. M., Kotlinowski, J., Caramalho, I., Magalhães, S., Soares, M. P., & Gordo, I. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003802 · Cited by 71
McCollister, B. D., Hoffman, M. G., Husain, M., & Vázquez‐Torres, A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01203-10 · Cited by 80
Kriegeskorte, A., Lorè, N. I., Bragonzi, A., Riva, C., Kelkenberg, M., Becker, K., Proctor, R. A., Peters, G., & Kahl, B. C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00742-15 · Cited by 81
Self-citationStudying bacterial infections through culture-independent approaches
Rogers, G. B., Carroll, M. P., & Bruce, K. D. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.013334-0 · Cited by 71
Ziegler, C., Goldmann, O., Hobeika, E., Geffers, R., Peters, G., & Medina, E. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100173 · Cited by 81
Self-citationHammer, N. D., Cassat, J. E., Noto, M. J., Lojek, L. J., Chadha, A. D., Schmitz, J. E., Creech, C. B., & Skaar, E. P. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.09.002 · Cited by 72
Becker, K., Laham, N. A., Fegeler, W., Proctor, R. A., Peters, G., & von Eiff, C. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00847-06 · Cited by 72
Self-citationMitchell, G., Gattuso, M., Grondin, G., Marsault, É., Bouarab, K., & Malouin, F. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01468-10 · Cited by 81
Host-dependent Induction of Transient Antibiotic Resistance: A Prelude to Treatment Failure
Kubicek-Sutherland, J. Z., Heithoff, D. M., Ersoy, S. C., Shimp, W. R., House, J. K., Marth, J. D., Smith, J. W., & Mahan, M. J. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.08.012 · Cited by 73
Genome-wide mutant profiling predicts the mechanism of a Lipid II binding antibiotic
Santiago, M., Lee, W., Fayad, A. G. A., Coe, K. A., Rajagopal, M., Do, T., Hennessen, F., Srisuknimit, V., Müller, R., Meredith, T. C., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0041-4 · Cited by 78
Pucelik, B., & Dąbrowski, J. M. (2022) · Advances in inorganic chemistry · doi:10.1016/bs.adioch.2021.12.003 · Cited by 93
Staphylococcus aureus Adaptation to the Skin in Health and Persistent/Recurrent Infections
Gehrke, A.-K. E., Giai, C., & Gómez, M. I. (2023) · Antibiotics · doi:10.3390/antibiotics12101520 · Cited by 58
“Considering the harsh skin microenvironment, a heterogeneous population of bacteria that presents diverse subpopulations has a higher probability of surviving during the stress conditions than a homogeneous population [16,17].”
BackgroundMerging chemical ecology with bacterial genome mining for secondary metabolite discovery
Vizcaino, M. I., Guo, X., & Crawford, J. M. (2013) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-013-1356-5 · Cited by 75
Modulation of virulence gene expression by cell wall active antibiotics in Staphylococcus aureus
Subrt, N., Mesak, L. R., & DAVIES, J. E. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr043 · Cited by 71
Guérillot, R., da Silva, A. G., Monk, I. R., Giulieri, S. G., Tomita, T., Alison, E., Porter, J., Pidot, S. J., Gao, W., Peleg, A. Y., et al. (2018) · mSphere · doi:10.1128/msphere.00550-17 · Cited by 74
Selective pressures during chronic infection drive microbial competition and cooperation
Baishya, J., & Wakeman, C. A. (2019) · npj Biofilms and Microbiomes · doi:10.1038/s41522-019-0089-2 · Cited by 70
Staphylococcus aureus small-colony variants: Formation, infection, and treatment
Zhou, S., Rao, Y., Li, J., Huang, Q., & Rao, X. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127040 · Cited by 75
Sass, A. M., Marchbank, A. M., Tullis, E. D., LiPuma, J. J., & Mahenthiralingam, E. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-373 · Cited by 79
Ferry, T., Uçkay, İ., Vaudaux, P. E., François, P., Schrenzel, J., Harbarth, S., Laurent, F. J., Bernard, L., Vandenesch, F., Étienne, J., et al. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0837-y · Cited by 70
Dean, M. A., Olsen, R. J., Long, S. W., Rosato, A. E., & Musser, J. M. (2014) · Infection and Immunity · doi:10.1128/iai.01487-13 · Cited by 69
Küehl, R., Morata, L., Meylan, S., Mensa, J., & Soriano, À. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz559 · Cited by 73
Future research needs involving pathogens in groundwater
Bradford, S. A., & Harvey, R. W. (2016) · Hydrogeology Journal · doi:10.1007/s10040-016-1501-0 · Cited by 69
Moriarty, T. F., Harris, L. G., Mooney, R. A., Wenke, J. C., Riool, M., Zaat, S. A. J., Moter, A., Schaer, T. P., Khanna, N., Küehl, R., et al. (2019) · Journal of Orthopaedic Research® · doi:10.1002/jor.24230 · Cited by 76
“Small colony variants (SCVs), subpopulations with a slow growth rate and atypical colony morphology, may develop and can only be detected in prolonged cultures.(99) According to the current hypothesis, bacteria may also enter a viable but non-culturable (VBNC) state in particular within biofilms, but also as planktoni…”
BackgroundVaudaux, P. E., Kelley, W. L., & Lew, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/507643 · Cited by 69
Trouillet‐Assant, S., Lelièvre, L., Martins-Simões, P., Gonzaga, L., Tasse, J., Valour, F., Rasigade, J., Vandenesch, F., Guedes, R. L. M., de Vasconcelos, A. T. R., et al. (2016) · Cellular Microbiology · doi:10.1111/cmi.12582 · Cited by 67
Inhibition of the ATP synthase sensitizes Staphylococcus aureus towards human antimicrobial peptides
Liu, L., Beck, C., Nøhr-Meldgaard, K., Peschel, A., Kretschmer, D., Ingmer, H., & Vestergaard, M. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-68146-4 · Cited by 67
Staphylococcus aureus: An Old Pathogen with New Weapons
Tang, Y., & Stratton, C. W. (2010) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2010.01.005 · Cited by 74
Tomenius, H. L., Pränting, M., Thulin, E., & Andersson, D. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068875 · Cited by 68
Bacteria tracking by in vivomagnetic resonance imaging
Hoerr, V., Tuchscherr, L. P. N., Hüve, J., Nippe, N., Loser, K., Glyvuk, N., Tsytsyura, Y., Holtkamp, M., Sunderkötter, C. H., Kärst, U., et al. (2013) · BMC Biology · doi:10.1186/1741-7007-11-63 · Cited by 70
Self-citationRajagopal, M., Martin, M. J., Santiago, M., Lee, W., Kos, V. N., Meredith, T., Gilmore, M. S., & Walker, S. (2016) · mBio · doi:10.1128/mbio.00950-16 · Cited by 64
Fernandez, A., Lechardeur, D., Derré-Bobillot, A., Couvé, E., Gaudu, P., & Gruss, A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000860 · Cited by 65
Bacterial determinants of importance in the virulence of Gallibacterium anatis in poultry
Persson, G., & Bojesen, A. M. (2015) · Veterinary Research · doi:10.1186/s13567-015-0206-z · Cited by 65
“SCVs are associated with increased persistence, recurrent infections and increased resistance towards antimicrobials [95].”
BackgroundLévy, J., Licini, L., Haelterman, E., Moris, P., Lestrate, P., Damaso, S., Belle, P. V., & Boutriau, D. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1011021 · Cited by 70
Yağcı, S., Hasçelik, G., Doğru, D., Özçelik, U., & Şener, B. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03742.x · Cited by 70
Kohler, C., von Eiff, C., Liebeke, M., McNamara, P. J., Lalk, M., Proctor, R. A., Hecker, M., & Engelmann, S. (2008) · Journal of Bacteriology · doi:10.1128/jb.00505-08 · Cited by 66
Self-citationSingh, R., Ray, P., Das, A., & Sharma, M. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.017046-0 · Cited by 63
Phenotypic heterogeneity: a bacterial virulence strategy
Weigel, W. A., & Dersch, P. (2018) · Microbes and Infection · doi:10.1016/j.micinf.2018.01.008 · Cited by 71
Non-thermal plasma-based inactivation of bacteria in water using a microfluidic reactor
Patinglag, L., Melling, L. M., Whitehead, K. A., Sawtell, D. A. G., Iles, A., & Shaw, K. J. (2021) · Water Research · doi:10.1016/j.watres.2021.117321 · Cited by 65
“aberrant form of bacteria generated in response to environmental stress, characterized with a slow growth rate, reduced metabolic activity and increased resistance to antibiotics, which are able to recover over time when provided with essential factors such as nutrients (Proctor et al., 2006).”
BackgroundSikder, A., Chaudhuri, A., Mondal, S., & Singh, N. D. P. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00150 · Cited by 64
Mayfield, J. A., Hammer, N. D., Kurker, R. C., Chen, T. K., Ojha, S., Skaar, E. P., & DuBois, J. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442335 · Cited by 63
Emerging Functions for the Staphylococcus aureus RNome
Guillet, J., Hallier, M., & Felden, B. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003767 · Cited by 55
Extremely fast amelioration of plasmid fitness costs by multiple functionally diverse pathways
Hall, J. P. J., Wright, R. C. T., Guymer, D., Harrison, E., & Brockhurst, M. A. (2019) · Microbiology · doi:10.1099/mic.0.000862 · Cited by 63
“aeruginosa and Staphylococcus aureus reflect adaptations enabling prolonged 203 infection of humans and animals (30,31).”
BackgroundBerditsch, M., Afonin, S., Reuster, J., Lux, H., Schkolin, K., Babii, O., Radchenko, D. S., Abdullah, I., William, N., Middel, V., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54212-z · Cited by 64
Birkenstock, T. A., Liebeke, M., Winstel, V., Krismer, B., Gekeler, C., Niemiec, M. J., Bisswanger, H., Lalk, M., & Peschel, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.288894 · Cited by 66
Tuchscherr, L. P. N., Löffler, B., Buzzola, F. R., & Sordelli, D. O. (2010) · Future Microbiology · doi:10.2217/fmb.10.147 · Cited by 63
Nguyen, H. A., Denis, O., Vergison, A., Theunis, A., Tulkens, P. M., Struelens, M. J., & Van Bambeke, F. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01145-08 · Cited by 62
A murine model of early Pseudomonas aeruginosa lung disease with transition to chronic infection
Bayes, H. K., Ritchie, N. D., Irvine, S., & Evans, T. J. (2016) · Scientific Reports · doi:10.1038/srep35838 · Cited by 68
Mashruwala, A. A., Gries, C. M., Scherr, T. D., Kielian, T., & Boyd, J. M. (2017) · Infection and Immunity · doi:10.1128/iai.00157-17 · Cited by 61
Richter, K., Thomas, N., Zhang, G., Prestidge, C. A., Coenye, T., Wormald, P., & Vreugde, S. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00280 · Cited by 64
Bär, J., Boumasmoud, M., Kouyos, R. D., Zinkernagel, A. S., & Vulin, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-72979-4 · Cited by 66
Atalla, H., Gyles, C., Jacob, C. L., Moisan, H., Malouin, F., & Mallard, B. (2008) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2008.0110 · Cited by 59
“S. aureus SCVs have atypical phenotypic properties that seem to be associated with disruption in the electron transport system (Proctor et al. , 2006).”
InfluentialRobertson, G. T., Bonventre, E. J., Doyle, T. B., Du, Q., Duncan, L. R., Morris, T. W., Roche, E. D., Yan, D., & Lynch, A. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01651-07 · Cited by 62
Bacterial Resistance to Antimicrobials
Wax, R. G., Lewis, K., Salyers, A. A., & Taber, H. W. (2007) · CRC Press eBooks · doi:10.1201/9781420008753 · Cited by 62
Selective Host Cell Death by Staphylococcus aureus: A Strategy for Bacterial Persistence
Missiakas, D. M., & Winstel, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.621733 · Cited by 66
DNA Repair in Staphylococcus aureus
Ha, K. P., & Edwards, A. M. (2021) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00091-21 · Cited by 73
Cao, S., Huseby, D. L., Brandis, G., & Hughes, D. (2017) · mBio · doi:10.1128/mbio.00358-17 · Cited by 75
The potential for bio-optical imaging of biomaterial-associated infection in vivo
Sjollema, J., Sharma, P. K., Dijkstra, R. J. B., van Dam, G. M., van der Mei, H. C., Engelsman, A. F., & Busscher, H. J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.068 · Cited by 64
Wolter, D. J., Onchiri, F., Emerson, J., Precit, M. R., Lee, M., McNamara, S., Nay, L., Blackledge, M., Uluer, A., Orenstein, D. M., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30365-0 · Cited by 64
Lannergård, J., Norström, T., & Hughes, D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00871-08 · Cited by 54
Immunometabolism in biofilm infection: lessons from cancer
Mirzaei, R., Sabokroo, N., Ahmadyousefi, Y., Motamedi, H., & Karampoor, S. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00435-2 · Cited by 63
Recent Advances in the Biomedical Applications of Functionalized Nanogels
Narayanan, K. B., Bhaskar, R., & Han, S. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122832 · Cited by 61
“Pathogenic bacteria can be phagocytosed by macrophages, which makes them evade the immune system and protects them against antibiotics attack, which makes them ready for recurrent infections [161].”
BackgroundEvolution of Staphylococcus aureus during human colonization and infection
Fitzgerald, J. R. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.04.020 · Cited by 68
Grundmeier, M., Tuchscherr, L., Brück, M., Viemann, D., Roth, J., Willscher, E., Becker, K., Peters, G., & Löffler, B. (2010) · The Journal of Infectious Diseases · doi:10.1086/651023 · Cited by 56
Self-citationBayston, R., Ashraf, W., & Smith, T. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm031 · Cited by 58
Varma, P., Nisha, N., Dinesh, K. R., Kumar, A. V., & Biswas, R. (2011) · Microbial Physiology · doi:10.1159/000328512 · Cited by 56
Tuchscherr, L. P. N., Buzzola, F. R., Álvarez, L., Lee, J. C., & Sordelli, D. O. (2008) · Infection and Immunity · doi:10.1128/iai.00874-08 · Cited by 58
Advances in the local and targeted delivery of anti-infective agents for management of osteomyelitis
Ford, C. A., & Cassat, J. E. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1372192 · Cited by 59
Dalhoff, A. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00022-14 · Cited by 63
Characterization of Clinical Enterococcus faecalis Small-Colony Variants
Wellinghausen, N., Chatterjee, I., Berger, A., Niederfuehr, A., Proctor, R. A., & Kahl, B. C. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00485-09 · Cited by 56
Self-citationSepahi, E., Tarighi, S., Ahmadi, F. S., & Bagheri, A. (2015) · The Journal of Microbiology · doi:10.1007/s12275-015-4203-8 · Cited by 62
High phenotypic diversity in infecting but not in colonizing Staphylococcus aureus populations
Goerke, C., Gressinger, M., Endler, K., Breitkopf, C., Wardecki, K., Stern, M., Wolz, C., & Kahl, B. C. (2007) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01423.x · Cited by 56
“Another mechanism of adaptation to long-term antibiotic therapy is the emergence of small colony variants (SCVs) (Kahl et al., 1998; 2003; Proctor et al., 2006) which are more resistant to antibiotics than the normal S.”
BackgroundSelf-citationThe importance of regulatory RNAs in Staphylococcus aureus
Tomasini, A., François, P., Howden, B. P., Fechter, P., Romby, P., & Caldelari, I. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.11.016 · Cited by 57
Antibiotic tolerance and the alternative lifestyles of Staphylococcus aureus
Bui, L. M. G., Conlon, B. P., & Kidd, S. P. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160061 · Cited by 64
Krishnegowda, D. N., Dhama, K., Mariappan, A. K., Palanivelu, M., Yatoo, M. I., Tiwari, R., Karthik, K., Bhatt, P., & Reddy, M. R. (2020) · Veterinary Quarterly · doi:10.1080/01652176.2020.1712495 · Cited by 57
“…variants (SCV) are seen in primary cultures of G. anatis and have varying hemolytic activity (Greenham & Hill 1962; Harbourne 1962; Janetschke & Risk 1970), and are related to protracted persistence, repeated infections, and emergence of resistance to antimicrobial agents (Proctor et al. 2006).”
BackgroundFoster, T. J., & Geoghegan, J. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397169-2.00037-8 · Cited by 66
Consequences of Metabolic Interactions during Staphylococcus aureus Infection
Lung, T. W. F., & Prince, A. S. (2020) · Toxins · doi:10.3390/toxins12090581 · Cited by 69
“SCVs are slow growing, have pinpoint colony size and a variety of mutations typically in genes associated with electron transport chain components such as menadione and heme [38].”
BackgroundTao, Q., Wu, Q., Zhang, Z., Liu, J., Tian, C., Huang, Z., Malakar, P. K., Pan, Y., & Zhao, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.906490 · Cited by 56
Gläser, R., Becker, K., von Eiff, C., Meyer‐Hoffert, U., & Harder, J. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.176 · Cited by 64
Self-citation
Metadata
- Authors
- Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G.
- Affiliations
- University of Wisconsin–Madison (US)
- University of Münster (DE)
- Universitätsklinikum des Saarlandes (DE)
- Corresponding author
- Proctor, Richard A.
- Venue
- Nature Reviews Microbiology
- Published
- 2006-04
- Volume
- 4
- Issue
- 4
- Pages
- 295-305
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2088960594
- Cited by
- 1,175
- References
- 116
- Citations by year
- 2026: 40 · 2025: 54 · 2024: 52 · 2023: 57 · 2022: 75 · 2021: 71 · 2020: 78 · 2019: 89 · 2018: 61 · 2017: 63 · 2016: 68 · 2015: 67 · 2014: 67 · 2013: 75 · 2012: 56
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- small colony variants, Staphylococcus aureus, metabolic deficiency, antibiotic resistance, persistent infection, recurrent infections, latent infection, bacterial identification, Staphylococcus
- MeSH terms
- Aminoglycosides, Animals, Bacteria, Bacterial Infections, Humans, Phenotype, Staphylococcus aureus, Genetic Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.